The marketing of a medicinal product in Europe generally requires authorisation from the competent authorities. An important part of this is the environmental risk assessment (ERA). One of the aims of the PREMIER project is to create a database containing ecotoxicological studies and studies on the fate of active pharmaceutical ingredients in the environment, which … Continue reading Environmental risk assessment of medicinal products for human use